Brandywine Global Investment Management Decreased Dte Energy Co (DTE) Stake; Tekla Capital Management Has Boosted By $1.81 Million Its Genmark Diagnostics (GNMK) Holding

January 13, 2018 - By Nellie Frank

Tekla Capital Management Llc increased Genmark Diagnostics Inc. (GNMK) stake by 215.75% reported in 2017Q3 SEC filing. Tekla Capital Management Llc acquired 201,400 shares as Genmark Diagnostics Inc. (GNMK)’s stock rose 23.38%. The Tekla Capital Management Llc holds 294,749 shares with $2.84M value, up from 93,349 last quarter. Genmark Diagnostics Inc. now has $252.06M valuation. The stock decreased 2.75% or $0.13 during the last trading session, reaching $4.6. About 357,944 shares traded. GenMark Diagnostics, Inc. (NASDAQ:GNMK) has risen 116.11% since January 13, 2017 and is uptrending. It has outperformed by 99.41% the S&P500.

Brandywine Global Investment Management Llc decreased Dte Energy Co (DTE) stake by 3.33% reported in 2017Q3 SEC filing. Brandywine Global Investment Management Llc sold 5,420 shares as Dte Energy Co (DTE)’s stock rose 8.06%. The Brandywine Global Investment Management Llc holds 157,382 shares with $16.90 million value, down from 162,802 last quarter. Dte Energy Co now has $18.64 billion valuation. The stock decreased 0.01% or $0.01 during the last trading session, reaching $103.92. About 1.31M shares traded or 30.23% up from the average. DTE Energy Company (NYSE:DTE) has risen 19.61% since January 13, 2017 and is uptrending. It has outperformed by 2.91% the S&P500.

Brandywine Global Investment Management Llc increased Express Scripts Hldg Co (NASDAQ:ESRX) stake by 16,781 shares to 277,421 valued at $17.57 million in 2017Q3. It also upped Natural Gas Services Group (NYSE:NGS) stake by 44,876 shares and now owns 184,727 shares. Lazard Ltd (NYSE:LAZ) was raised too.

Since August 2, 2017, it had 0 insider purchases, and 2 selling transactions for $1.47 million activity. Steward Larry E also sold $1.08 million worth of DTE Energy Company (NYSE:DTE) on Wednesday, August 2. Stiers Mark W sold $399,629 worth of stock.

Analysts await DTE Energy Company (NYSE:DTE) to report earnings on February, 8. They expect $1.21 earnings per share, up 49.38% or $0.40 from last year’s $0.81 per share. DTE’s profit will be $217.06 million for 21.47 P/E if the $1.21 EPS becomes a reality. After $1.48 actual earnings per share reported by DTE Energy Company for the previous quarter, Wall Street now forecasts -18.24% negative EPS growth.

Among 9 analysts covering Dte Energy Company (NYSE:DTE), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Dte Energy Company had 23 analyst reports since July 28, 2015 according to SRatingsIntel. Barclays Capital maintained DTE Energy Company (NYSE:DTE) rating on Thursday, April 7. Barclays Capital has “Overweight” rating and $97 target. The company was initiated on Monday, November 14 by Jefferies. Jefferies maintained DTE Energy Company (NYSE:DTE) rating on Thursday, July 27. Jefferies has “Buy” rating and $12100 target. Guggenheim maintained it with “Buy” rating and $121.0 target in Tuesday, January 2 report. KeyBanc Capital Markets maintained DTE Energy Company (NYSE:DTE) rating on Wednesday, October 18. KeyBanc Capital Markets has “Buy” rating and $114.0 target. The company was maintained on Monday, August 28 by Jefferies. The company was maintained on Monday, October 16 by Jefferies. The rating was maintained by UBS with “Buy” on Thursday, September 29. The company was initiated on Wednesday, January 25 by Credit Suisse. Wells Fargo upgraded DTE Energy Company (NYSE:DTE) rating on Friday, January 12. Wells Fargo has “Buy” rating and $116.0 target.

Investors sentiment decreased to 0.96 in Q3 2017. Its down 0.10, from 1.06 in 2017Q2. It turned negative, as 35 investors sold DTE shares while 176 reduced holdings. 44 funds opened positions while 158 raised stakes. 119.85 million shares or 3.77% less from 124.54 million shares in 2017Q2 were reported. Federated Invsts Pa accumulated 0.04% or 141,900 shares. Ny State Common Retirement Fund holds 425,070 shares or 0.06% of its portfolio. Amica Pension Fund Board Of Trustees holds 6,975 shares. First Allied Advisory Ser holds 0.04% or 9,001 shares. National Planning Corp owns 2,940 shares for 0.06% of their portfolio. Loring Wolcott Coolidge Fiduciary Advisors Llp Ma accumulated 32 shares. Tru Com Of Toledo Na Oh owns 9,411 shares. Suntrust Banks reported 25,868 shares. White Pine Inv reported 7,640 shares. Caxton Assocs Ltd Partnership holds 0.01% or 2,800 shares. Howe Rusling reported 657 shares. Advsr Asset accumulated 36,982 shares or 0.07% of the stock. Lazard Asset Mngmt Limited Liability Corporation accumulated 53 shares. Gabelli Funds Ltd reported 21,000 shares or 0.01% of all its holdings. Alliancebernstein Limited Partnership invested in 0.03% or 320,791 shares.

Investors sentiment decreased to 1.88 in 2017 Q3. Its down 2.12, from 4 in 2017Q2. It fall, as 11 investors sold GNMK shares while 15 reduced holdings. 11 funds opened positions while 38 raised stakes. 56.57 million shares or 46.84% less from 106.41 million shares in 2017Q2 were reported. Federated Invsts Pa invested 0.01% of its portfolio in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Tiaa Cref Inv Management Ltd Liability accumulated 170,731 shares. State Board Of Administration Of Florida Retirement holds 0% or 26,565 shares. Moreover, Voya Investment Mgmt Limited Com has 0% invested in GenMark Diagnostics, Inc. (NASDAQ:GNMK) for 19,725 shares. California Employees Retirement Sys accumulated 50,700 shares. Weiss Multi stated it has 93,000 shares. Alphaone Inv Limited Company has invested 0.01% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Cadian Cap Management Lp, New York-based fund reported 4.03M shares. Rmb Capital Management Limited Liability Company invested 0.02% of its portfolio in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Ubs Asset Mngmt Americas, Illinois-based fund reported 23,400 shares. Adage Prtn Group Inc Lc invested in 1.05 million shares or 0.02% of the stock. Northern Trust Corporation, Illinois-based fund reported 699,201 shares. Glenmede Trust Na owns 1,000 shares. Ameritas Invest stated it has 0% in GenMark Diagnostics, Inc. (NASDAQ:GNMK). Citadel Ltd owns 88,143 shares.

Among 6 analysts covering Genmark Diagnostics (NASDAQ:GNMK), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Genmark Diagnostics had 18 analyst reports since October 14, 2015 according to SRatingsIntel. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) has “Buy” rating given on Tuesday, January 24 by Needham. Canaccord Genuity maintained it with “Buy” rating and $14.0 target in Monday, September 25 report. The rating was upgraded by Cowen & Co on Friday, September 16 to “Outperform”. Canaccord Genuity maintained GenMark Diagnostics, Inc. (NASDAQ:GNMK) on Monday, June 12 with “Buy” rating. Needham maintained it with “Buy” rating and $1700 target in Monday, June 12 report. The stock of GenMark Diagnostics, Inc. (NASDAQ:GNMK) has “Market Perform” rating given on Friday, November 3 by Raymond James. Needham maintained GenMark Diagnostics, Inc. (NASDAQ:GNMK) on Wednesday, August 30 with “Buy” rating. The firm has “Buy” rating by Canaccord Genuity given on Monday, August 7. Canaccord Genuity maintained it with “Buy” rating and $10 target in Friday, November 3 report. The firm has “Buy” rating given on Wednesday, August 2 by Needham.

Tekla Capital Management Llc decreased Adaptimmune Therapeutics Plc stake by 531,000 shares to 935,368 valued at $7.66M in 2017Q3. It also reduced Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) stake by 145,000 shares and now owns 859,322 shares. Celgene Corporation (NASDAQ:CELG) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>